IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intra-Cellular Therapies Inc.

CUSIP: 46116X010 | 1 institutional holders

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

General American Investors Co Inc299,942
0.0% of portfolio›$6.5K
StyleTurnoverLocationFiled
General American Investors Co Inc
299,942$6.5K0.0%CoreLowNew York, NY2018-10-26